1Merson M,Black RE,Mills AJ,et al.International public health:Dis-ease,programs,systems,and policies.Sudbury Massachusetts:Jones,Bartlett,2005:331-372.
2Frank E,Thase ME.Natural history and preventative treatment of recur-rent mood disorders.Annu Rev Med,1999,50:453-468.
3The World Health Organization.The World Health Report2004.Geneva:World Health Organization,2005.127-131.
4中华医学会精神科分会.中国精神障碍分类与诊断标准第3版.山东科技出版社.2001.
5Silverstone PH,Ravindran A.Once daily venlafaxine extended release(XR)compared with fluoxetine in outpatients with depression and anxie-ty.J Clin Psychiatry,1999,60:22-23.
6Clerc CE,Rulmy P,Verdeau Pailles J.A double-blind comparison of ven-lafaxine and fluoxetine in patients hospitalized for major depression and melancholia.Int Clin Psychopharmacol,1994,9:139-143.
9Linde K,Berner M,Egger M.John’s wort for depression an meta-analy-sis of randomized controlled trials.Br J Psychiatry,2005,186:99-107.
10Thiede HM,Walper A.Inhibition of MAO and COMT by hypericum ex-tracts and hypericin.J Geriatr Psychiatry Neurol,1994,7:54-56.
二级参考文献10
1Horst WD, Preskom SH. Mechanisms of action and clinical characteristics of three atypical antidepressants: Venlafaxine, nefazodone, blipropion [ J ].J Affect D/s, 1998,51( 3 ):237 - 254.
2Stahl SM, Entsuah R, Rudolph RL. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression[ J ]. Biol Psychiatry,2002,52(12):1166 - 1174.
3兰志银.抗抑郁新药 万法拉辛[J].国外医学·合成药生物药剂分册,1996,(3):17-18.
4Harrison CL, Ferrier N, Young AH. Tolerability of high-dose venlafaxineindepressiedpatients [J]. J Psychopharmacol, 2004, 18(2) :200 - 204.
5Gasto C, Navarro V, Marcos T, et al.Single-blind comparison of venlafaxine and nortriptyline in elderly major depression [J]. J Clin Psychopharmacol, 2003,23 (1) : 21 - 26.
6Cunnigham L A. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression[J]. Ann Clln Psychlatry ,1997 ,9 :15 7 -158.
7Silverstone P H, Ravindran A, Once-daily venlafaxine extended release(XR) compared with fluoxetine in outpatients with depression and anxiety [ J ]. J Clin Psychiatry, 1999,60:22 - 23.
8Feigher J P. Mechanism of action of antidepressant medication [ J ]. J Clin Psychiatry, 1999,60(Suppl 4) :4 - 10.
9Fawcett J. The detection and consequence of anxiety in clinical depression [ J]. J Clin Psychiatry, 1997,58( Suppl 8 ) :35-57.
